Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can Platelet Rich Plasma Reduce the Level of Pro-Inflammatory Synovial Fluid Biomarkers Following an Anterior Cruciate Ligament Tear

NCT03389685 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT03389685
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03389685 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can Platelet Rich Plasma Reduce the Level of Pro-Inflammatory Synovial Fluid Biomarkers Following an Anterior Cruciate Ligament Tear
Lead sponsor
NYU Langone Health
Phase
Phase 2
Overall status
Withdrawn
Start date
September 9, 2018
Completion date
February 29, 2024
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acl - anterior cruciate ligament rupture, acl injury